CDKN2A and neoplasm: Deletions in CDKN2A (cyclin-dependent kinase inhibitor 2A) impair the cell cycle checkpoint, whereas aberrant activation of stem cell markers such as SRY-Box transcription factor 2 (SOX2) supports tumor cell self-renewal and invasion.